25-Hydroxycholesterol promotes fibroblast-mediated tissue remodeling through NF-κB dependent pathway
Authors:
- Hisatoshi SugiuraHSHisatoshi Sugiura
- Akira KoaraiAKAkira Koarai
- Takashi KikuchiTKTakashi Kikuchi
- Masataka HiramatsuMHMasataka Hiramatsu
- Hiroki KawabataHKHiroki Kawabata
- Keiichiro AkamatsuKAKeiichiro Akamatsu
- Tsunahiko HiranoTHTsunahiko Hirano
- Masanori NakanishiMNMasanori Nakanishi
- Kazuto MatsunagaKMKazuto Matsunaga
- Yoshiaki MinakataYoshiaki Minakata
- Masakazu IchinoseMIMasakazu Ichinose
- 1 May 2013
- journal article
- research article
- Published by Elsevier in Experimental Cell Research
- Vol. 319 (8) , 1176-1186
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- ATF3 protects against atherosclerosis by suppressing 25-hydroxycholesterol–induced lipid body formationJournal of Experimental Medicine, 2012
- Mouse and human lung fibroblasts regulate dendritic cell trafficking, airway inflammation, and fibrosis through integrin αvβ8–mediated activation of TGF-βJournal of Clinical Investigation, 2011
- Marked upregulation of cholesterol 25-hydroxylase expression by lipopolysaccharideJournal of Lipid Research, 2009
- 25-Hydroxycholesterol secreted by macrophages in response to Toll-like receptor activation suppresses immunoglobulin A productionProceedings of the National Academy of Sciences, 2009
- Emerging Concepts in the Pathogenesis of Lung FibrosisThe American Journal of Pathology, 2009
- Peroxynitrite augments fibroblast-mediated tissue remodeling via myofibroblast differentiationAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2008
- The MyofibroblastThe American Journal of Pathology, 2007
- Cigarette Smoke Stimulates Matrix Metalloproteinase-2 Activity via EGR-1 in Human Lung FibroblastsAmerican Journal of Respiratory Cell and Molecular Biology, 2007
- Cholesterol and 25-Hydroxycholesterol Inhibit Activation of SREBPs by Different Mechanisms, Both Involving SCAP and InsigsJournal of Biological Chemistry, 2004
- Modulation of matrix metalloproteinase production from human lung fibroblasts by type 4 phosphodiesterase inhibitorsLife Sciences, 2004